Investment in Cancer Research in 2022
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research investment was fairly flat from 2019-2022, although the number of new and in-progress projects continued to decline. Research investment in breast, prostate and blood cancers declined from 2020 on and investment in operating grants fell steeply from 2020, particularly investments offered through national priority-driven competitions. Strategies employed by cancer research funders to mitigate the impacts of the pandemic on cancer research funding are described. This report has an accompanying Excel file as well as dashboard tools that expand on the findings in the report. To access this report, click here.

Effective January 1st, 2021, CCRA welcomes new Advisory Board chair, Dr. Paula Robson. Paula is the Scientific Director of the Cancer Strategic Clinical Network, and Scientific Director and co-lead of Cancer Research & Analytics for Cancer Care Alberta in Alberta Health Services....
The Canadian Partnership Against Cancer is calling on partners in health care and communities across Canada to end cervical cancer in Canada by 2040. The Partnership is leading the development and implementation of a Canadian plan to achieve the World Health Organization (WHO)’s ...